Synexus Increases Osteoporosis Clinical Trial Capacity

MANCHESTER, England--(BUSINESS WIRE)--Synexus has significantly increased its capacity to recruit and run global osteoporosis trials by increasing the number of DEXA scanners at its hub sites by a third. According to the American College of Radiology the DEXA scan is the most reliable way of identifying osteoporosis and is the best test for measuring bone mineral density [1].

MORE ON THIS TOPIC